Imunon Inc IMNN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.33quote price arrow up+0.02 (+1.53%)
Volume
51,915
52 week range
0.48 - 2.00
Loading...
  • Open1.29
  • Day High1.39
  • Day Low1.26
  • Prev Close1.31
  • 52 Week High2.00
  • 52 Week High Date03/28/24
  • 52 Week Low0.48
  • 52 Week Low Date02/14/24

Key Stats

  • Market Cap12.502M
  • Shares Out9.40M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change95.59

KEY STATS

  • Open1.29
  • Day High1.39
  • Day Low1.26
  • Prev Close1.31
  • 52 Week High2.00
  • 52 Week High Date03/28/24
  • 52 Week Low0.48
  • 52 Week Low Date02/14/24
  • Market Cap12.502M
  • Shares Out9.40M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.07
  • YTD % Change95.59

RATIOS/PROFITABILITY

  • EPS (TTM)-2.17
  • P/E (TTM)-0.61
  • Fwd P/E (NTM)-0.59
  • EBITDA (TTM)-20.782M
  • ROE (TTM)-91.37%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-22,287.62%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Imunon Inc

 

Profile

MORE
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of...
Michael Tardugno
Executive Chairman of the Board
Jeffrey Church CPA
Chief Financial Officer, Executive Vice President
Khursheed Anwer Ph.D.
Executive Vice President, Chief Scientific Officer
Sebastien Hazard
Executive Vice President, Chief Medical Officer
Address
997 Lenox Dr Ste 100
Lawrenceville, NJ
08648
United States

Top Peers

SYMBOLLASTCHG%CHG
GNPX
Genprex Inc
2.38+0.02+0.85%
KPRX
Kiora Pharmaceuticals Inc
0.5133-0.0293-5.3999%
NNVC
NanoViricides Inc
1.13-0.07-5.83%
COEP
Coeptis Therapeutics Holdings Inc
0.36-0.0096-2.5974%
NCNA
NuCana PLC
3.95-0.01-0.38%